Christopher S. Badorrek, Ph.D. - Publications

Affiliations: 
2006 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Structural and Chemical Biology of the Transcriptome

4/11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Dash C, Scarth BJ, Badorrek C, Götte M, Le Grice SFJ. Examining the ribonuclease H primer grip of HIV-1 reverse transcriptase by charge neutralization of RNA/DNA hybrids Nucleic Acids Research. 36: 6363-6371. PMID 18836193 DOI: 10.1093/Nar/Gkn678  0.358
2008 Legiewicz M, Badorrek CS, Turner KB, Fabris D, Hamm TE, Rekosh D, Hammarskjöld ML, Le Grice SF. Resistance to RevM10 inhibition reflects a conformational switch in the HIV-1 Rev response element. Proceedings of the National Academy of Sciences of the United States of America. 105: 14365-70. PMID 18776047 DOI: 10.1073/Pnas.0804461105  0.567
2006 Badorrek CS, Weeks KM. Architecture of a gamma retroviral genomic RNA dimer. Biochemistry. 45: 12664-72. PMID 17042483 DOI: 10.1021/Bi060521K  0.739
2005 Badorrek CS, Weeks KM. RNA flexibility in the dimerization domain of a gamma retrovirus. Nature Chemical Biology. 1: 104-11. PMID 16408007 DOI: 10.1038/Nchembio712  0.803
Low-probability matches (unlikely to be authored by this person)
2006 Badorrek CS, Gherghe CM, Weeks KM. Structure of an RNA switch that enforces stringent retroviral genomic RNA dimerization. Proceedings of the National Academy of Sciences of the United States of America. 103: 13640-5. PMID 16945907 DOI: 10.1073/Pnas.0606156103  0.221
2019 Rusnak JM, Glass PJ, Weaver SC, Sabourin CL, Glenn AM, Klimstra W, Badorrek CS, Nasar F, Ward LA. Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule. Viruses. 11. PMID 31480472 DOI: 10.3390/V11090807  0.074
2019 Rudge TL, Sankovich KA, Niemuth NA, Anderson MS, Badorrek CS, Skomrock ND, Cirimotich CM, Sabourin CL. Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples. Plos One. 14: e0215457. PMID 30998735 DOI: 10.1371/journal.pone.0215457  0.052
2022 Rudge TL, Machesky NJ, Sankovich KA, Lemmon EE, Badorrek CS, Overman R, Niemuth NA, Anderson MS. Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination-Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay. Vaccines. 10. PMID 36016099 DOI: 10.3390/vaccines10081211  0.041
2020 Anderson MS, Niemuth NA, Sabourin CL, Badorrek CS, Bounds CE, Rudge TL. Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay. Plos One. 15: e0238196. PMID 32841291 DOI: 10.1371/journal.pone.0238196  0.039
2017 ElSherif MS, Brown C, MacKinnon-Cameron D, Li L, Racine T, Alimonti J, Rudge TL, Sabourin C, Silvera P, Hooper JW, Kwilas SA, Kilgore N, Badorrek C, Ramsey WJ, Heppner DG, et al. Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 189: E819-E827. PMID 28630358 DOI: 10.1503/cmaj.170074  0.039
2020 Niemuth NA, Rudge TL, Sankovich KA, Anderson MS, Skomrock ND, Badorrek CS, Sabourin CL. Method feasibility for cross-species testing, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for non-human primate serum samples. Plos One. 15: e0241016. PMID 33119638 DOI: 10.1371/journal.pone.0241016  0.036
Hide low-probability matches.